Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shaanxi Dideu Medichem

Shaanxi Dideu Medichem
Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shaanxi Dideu Medichem between 3 Jun 2025 and 4 Mar 2026. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Shaanxi Dideu Medichem
Retatrutide
Tested 6 Samples
Last test 4 Mar 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Shaanxi Dideu Medichem

Samples are tested in commercial labs

Tests Count

6

Scores

AVG4.9MIN0.0MAX7.4

Last

4 Mar 2026

First

3 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
29 Jan 2026View0.010mg
⚠️ Sample does not contain Retatrutide
(no batch ID)No Label / Red Crimp / Clear CapLab EPublic
13 Dec 2025View7.220mg21.2mg+6.0%99.70%(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
4 Nov 2025View7.45mg4.92mg-1.6%99.66%(no batch ID)No Label / Silver Crimp / Orange CapLab EPublic
29 Oct 2025View4.35mg6.06mg+21.2%99.61%(no batch ID)No Label / Silver Crimp / Blue CapLab EPublic
3 Jun 2025View6.420mg22.1mg+10.5%99.98%(no batch ID)No Label / Silver Crimp / Red CapLab EPublic